Neurological biomarkers market size was valued at $5.4 billion in 2021, and is estimated to reach $18.9 billion by 2031, growing at a CAGR of 13.6% from 2022 to 2031. Ever-increasing rise in the incidence of Alzheimer’s and Parkinson’s is anticipated to contribute toward the robust growth of neurological biomarkers among these two applications. In …
Tag Archives: Neurological Biomarkers Market
Neurological Biomarkers Market Growing at a CAGR of 10.1% | Forecast, 2018 to 2025
Neurological Biomarkers Market for Alzheimer’s and Parkinson’s Disease: Global Opportunity Analysis and Industry Forecast, 2017-2025. The global market was valued at $3,958.5 million in 2017 and is projected to reach $8,579.9 million by 2025, growing at a CAGR of 10.1% from 2018 to 2025. China accounted for one-ninth of the total market for neurological biomarkers …
Neurological Biomarkers Market Report Study on Challenges, Application and Opportunities to 2025
Neurological Biomarkers market was valued at $3,958.5 million in 2017, and is projected to reach $8,579.9 million by 2025, growing at a CAGR of 10.1% from 2018 to 2025. China accounted for one-ninth share of the total market of neurological biomarkers for Alzheimers in 2017. The neurological biomarkers market for Alzheimers disease generated a revenue of …
Neurological Biomarkers Market for Alzheimers and Parkinsons Diseases Expected to Reach $8,579.9 Million by 2025
The neurological biomarkers market for Alzheimers disease generated a revenue of $2,636.7 million in 2017, and is expected to reach $6,122.5 million by 2025, registering a CAGR of 11.1% from 2018 to 2025. Conversely, neurological biomarkers market for Parkinsons disease generated a revenue of $1,321.8 million in 2017, and is expected to reach $2,457.4 million …
Neurological Biomarkers Market Analysis Insights by Latest Trends, Future Growth, Revenue and Demand 2030
The neurological biomarkers market for Alzheimers disease generated a revenue of $2,636.7 million in 2017, and is expected to reach $6,122.5 million by 2025, registering a CAGR of 11.1% from 2018 to 2025. Conversely, neurological biomarkers market for Parkinsons disease generated a revenue of $1,321.8 million in 2017, and is expected to reach $2,457.4 million …